Novartis Investigative Site

Wheaton, Illinois 60187

0 studies enrolling now · 2 studies all time

What they study most

Age-Related Macular Degeneration, Diabetic Macular Edema

Studies at this site

• Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema — Completed
• Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections — Stopped early